Genetic Technologies
GENE
#10486
Rank
S$4.8 M
Marketcap
S$0.99
Share price
0.00%
Change (1 day)
-69.65%
Change (1 year)

Genetic Technologies (GENE) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$3.77 Million

According to Genetic Technologies's latest financial reports the company's total liabilities are S$3.77 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Genetic Technologies - Total liabilities on balance sheet (from 2004 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-06-30S$3.94 M19.47%
2023-06-30S$3.3 M-20.92%
2022-06-30S$4.18 M187.6%
2021-06-30S$1.45 M-7.48%
2020-06-30S$1.57 M10.79%
2019-06-30S$1.41 M-3.35%
2018-06-30S$1.46 M-9.32%
2017-06-30S$1.61 M14.31%
2016-06-30S$1.41 M-22.24%
2015-06-30S$1.82 M-68.37%
2014-06-30S$5.75 M93.72%
2013-06-30S$2.97 M12.26%
2012-06-30S$2.64 M-4.35%
2011-06-30S$2.76 M-7.56%
2010-06-30S$2.99 M-33.52%
2009-06-30S$4.5 M4.33%
2008-06-30S$4.31 M-0.7%
2007-06-30S$4.34 M-11.99%
2006-06-30S$4.93 M-41.3%
2005-06-30S$8.41 M33.52%
2004-06-30S$6.29 M99.01%
2003-06-30S$3.16 M53.41%
2002-06-30S$2.06 M46.84%
2001-06-30S$1.4 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eterna Therapeutics
ERNA
S$3.37 M-10.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
S$0.46 B 12,086.42%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$12.37 B 327,407.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$11.43 B 302,451.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
S$70 M 1,752.80%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Danaher
DHR
S$37.34 B 988,293.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$67.21 B 1,778,850.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
S$1.63 B 43,099.89%๐Ÿ‡บ๐Ÿ‡ธ USA